{"title":"尼可地尔治疗冠心病临床应用的新进展","authors":"Lingbo Wang, Chengguo Wang","doi":"10.26689/cr.v1i1.5057","DOIUrl":null,"url":null,"abstract":"Nicorandil (NIC) is a calcium channel blocker, which has been widely used in the treatment of coronary heart disease (CHD). Although NIC has shown good efficacy and safety clinically, there are still some unresolved issues with its therapeutic mechanism and pathway of action. Studies in recent years have shown that the clinical application of NIC in the treatment of CHD has made new progress, such as being widely used in stable angina pectoris (AP), myocardial infarction, and percutaneous coronary intervention (PCI). In this article, we discuss the new progress of NIC in the treatment of CHD.","PeriodicalId":80890,"journal":{"name":"Cardiovascular reviews & reports","volume":"59 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2023-06-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"New Progress of Clinical Application of Nicorandil in the Treatment of Coronary Heart Disease\",\"authors\":\"Lingbo Wang, Chengguo Wang\",\"doi\":\"10.26689/cr.v1i1.5057\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Nicorandil (NIC) is a calcium channel blocker, which has been widely used in the treatment of coronary heart disease (CHD). Although NIC has shown good efficacy and safety clinically, there are still some unresolved issues with its therapeutic mechanism and pathway of action. Studies in recent years have shown that the clinical application of NIC in the treatment of CHD has made new progress, such as being widely used in stable angina pectoris (AP), myocardial infarction, and percutaneous coronary intervention (PCI). In this article, we discuss the new progress of NIC in the treatment of CHD.\",\"PeriodicalId\":80890,\"journal\":{\"name\":\"Cardiovascular reviews & reports\",\"volume\":\"59 1\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2023-06-23\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Cardiovascular reviews & reports\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.26689/cr.v1i1.5057\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Cardiovascular reviews & reports","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.26689/cr.v1i1.5057","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
New Progress of Clinical Application of Nicorandil in the Treatment of Coronary Heart Disease
Nicorandil (NIC) is a calcium channel blocker, which has been widely used in the treatment of coronary heart disease (CHD). Although NIC has shown good efficacy and safety clinically, there are still some unresolved issues with its therapeutic mechanism and pathway of action. Studies in recent years have shown that the clinical application of NIC in the treatment of CHD has made new progress, such as being widely used in stable angina pectoris (AP), myocardial infarction, and percutaneous coronary intervention (PCI). In this article, we discuss the new progress of NIC in the treatment of CHD.
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
